Steven I. Engel

Steven I. Engel is currently Senior Principal Scientist in Worldwide Regulatory Affairs for Merck & Co., Inc. He is also Principal Consultant for Drug Development and Regulatory Strategies, LLC . Dr. Engel brings an established track record of drug and biologic development expertise to the industry for the last 25 years. He has held increasingly more senior positions of responsibility for global regulatory strategy, registrations and quality compliance functions in companies such as Cyanamid, Abbott Laboratories, Otsuka, Baxter Healthcare, Cubist, Vertex and Par Pharmaceuticals, acting as Vice President of Regulatory Affairs in the last four. He has a proven track record of development and implementation of global regulatory strategies leading to multiple drug and biologic product registrations across several therapeutic areas in major, minor and emerging markets. Dr. Engel earned bachelor degrees in biology and pharmacy from Drake University, a Master’s degree in pharmacology from the University of North Carolinain Chapel Hill and a PharmD degree while on faculty at the University of Florida.